BIXT
BIOXYTRAN, INCCompany Information
- Company Name
- BIOXYTRAN, INC
- CIK
- CIK0001445815
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BIXT: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BIXT
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-18
- Last sale
- —
- Shares purchased (TTM)
- 210,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2018-06-30
- Institutional shares owned
- 25,000
- Shares outstanding
- 110,436,350
- Ownership
- 0.02%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -0.10%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Patents Gross | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Assets Noncurrent | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Loans Payable Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Short Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 1 | 1 | 0 | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | 2 | 2 | ||||||
| Liabilities Current | 5 | 5 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 3 | 2 | ||||||
| Liabilities | 5 | 5 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 3 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | - | - | - | - | - | - | - | 17 | - | - | - | 13 | ||||||
| Additional Paid In Capital | 19 | 19 | 18 | 17 | 17 | 17 | 17 | - | 16 | 16 | 13 | 13 | ||||||
| Minority Interest | - | - | - | - | - | - | - | - | -1 | -1 | -1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -24 | -23 | -21 | -21 | -20 | -20 | -19 | -18 | -17 | -16 | -16 | -15 | ||||||
| Stockholders Equity | -5 | -4 | -3 | -3 | -3 | -3 | -2 | -1 | -1 | -1 | -3 | -2 | ||||||
| Liabilities And Stockholders Equity | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Preferred Stock Shares Issued | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 29 | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 29 | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 115 | 113 | 108 | 89 | 89 | 89 | 87 | 82 | 177 | 173 | 145 | 144 | ||||||
| Shares Outstanding | 115 | 113 | 108 | 89 | 89 | 89 | 87 | 82 | 177 | 173 | 145 | 144 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOXYTRAN, INC (BIXT) — SEC Financial Statements & Analysis
BIOXYTRAN, INC (BIXT) is a pharmaceutical preparations company, incorporated in NV. BIOXYTRAN, INC trades on OTC as: BIXT. BIOXYTRAN, INC (BIXT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, BIOXYTRAN, INC carries a market cap of $2.97M, a P/E ratio of -0.85x, a P/B ratio of -0.60x, an enterprise value of $3.96M, and an EV/EBITDA multiple of -1.07x. On profitability, it posts a Return on Equity (ROE) of 92.23% and a Return on Assets (ROA) of -1453.04%. Per share, it reports EPS of $-0.03, diluted EPS of $-0.03, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 42.64% year-over-year and EPS growth of 10.81% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-5.10M, a debt-to-equity ratio of -1.07x, a debt ratio of 15.82, an interest coverage ratio of -25.47x, free cash flow of $-903.35K (TTM), and net debt of $983.21K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.97M
- P/E TTM
- -0.85x
- EPS TTM
- $-0.03
- P/B TTM
- -0.60x
- ROE TTM
- 92.23%
- ROA TTM
- -1453.04%
- Debt To Equity
- -1.07x
- Free Cash Flow TTM
- $-903.35K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOXYTRAN, INC in?
BIOXYTRAN, INC (BIXT) operates in the Pharmaceutical Preparations industry.
What exchange does BIXT trade on?
BIOXYTRAN, INC (BIXT) trades on the OTC.
Where is BIOXYTRAN, INC incorporated?
BIOXYTRAN, INC is incorporated in NV.
When was BIOXYTRAN, INC (BIXT)'s most recent SEC filing?
BIOXYTRAN, INC (BIXT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is BIXT's market cap?
BIOXYTRAN, INC (BIXT) has a market capitalization of $2.97M as of 2026-06-30.
What is BIXT's EPS (earnings per share)?
BIOXYTRAN, INC (BIXT)'s trailing twelve month EPS is $-0.03 as of 2026-06-30.
What is BIXT's ROE (return on equity)?
BIOXYTRAN, INC (BIXT)'s trailing twelve month Return on Equity (ROE) is 92.23% as of 2026-06-30.
What is BIXT's ROA (return on assets)?
BIOXYTRAN, INC (BIXT)'s trailing twelve month Return on Assets (ROA) is -1453.04% as of 2026-06-30.
What is BIXT's EV/EBITDA?
BIOXYTRAN, INC (BIXT)'s trailing twelve month EV/EBITDA is -1.07x as of 2026-06-30.